Cargando…
Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma
Tumor-associated (TA) autoantibodies have been identified at the early tumor stage before developing clinical symptoms, which holds hope for early cancer diagnosis. We identified a TA autoantibody from HBx-transgenic (HBx-tg) hepatocellular carcinoma (HCC) model mouse, characterized its target antig...
Autores principales: | Heo, Chang-Kyu, Hwang, Hai-Min, Lim, Won-Hee, Lee, Hye-Jung, Yoo, Jong-Shin, Lim, Kook-Jin, Cho, Eun-Wie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766137/ https://www.ncbi.nlm.nih.gov/pubmed/33352757 http://dx.doi.org/10.3390/ijms21249718 |
Ejemplares similares
-
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA
por: Heo, Chang-Kyu, et al.
Publicado: (2022) -
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2019) -
Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer
por: HEO, CHANG-KYU, et al.
Publicado: (2012) -
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
por: Hwang, Hai-Min, et al.
Publicado: (2018) -
Status of the ATIC experiment
por: Zatsepin, V I, et al.
Publicado: (2001)